Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease

Atherosclerosis

Volumn 188, Issue 2, 2006, Pages 231-244

  Gable, D R ^a   Hurel, S J ^b   Humphries, S E ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Adiponectin; Cardiovascular disease; Metabolic syndrome; Single nucleotide polymorphism; Type 2 diabetes mellitus

Indexed keywords

ADENYLATE KINASE; ADIPONECTIN; CYCLIC AMP; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ALLELE; ANTIINFLAMMATORY ACTIVITY; ATHEROMA; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; GENE; GENETIC VARIABILITY; HUMAN; INFLAMMATION; INSULIN RESISTANCE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCREENING; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION;

ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; CARDIOVASCULAR DISEASES; GENETIC VARIATION; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; RISK FACTORS; VARIATION (GENETICS);

EID: 33748086764     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.02.010     Document Type: Review

References (135)

1. Flegal K.M., Carroll M.D., Ogden C.L., and Johnson C.L. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288 (2002) 1723-1727
2. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
3. Isomaa B., Almgren P., Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
4. Alberti K.G.M.M., Zimmet P., and Shaw J. The metabolic syndrome-a new worldwide definition. The Lancet 366 (2005) 1059-1062
5. Kahn R., Buse J., Ferrannini E., and Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28 (2005) 2289-2304
6. Rajala M.W., and Scherer P.E. Minireview: the adipocyte-at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144 (2003) 3765-3773
7. Hug C., and Lodish H.F. Visfatin: a new adipokine. Science 307 (2005) 366-367
8. Arita Y., Kihara S., Ouchi N., et al. Paradoxical decrease of an adipose-specific protein; adiponectin, in obesity. Biochem Biophys Res Commun 257 (1999) 79-83
9. Halleux C.M., Takahashi M., Delporte M.L., et al. Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochem Biophys Res Commun 288 (2001) 1102-1107
10. Shapiro L., and Scherer P.E. The crystal structure of a compliment C1q family protein suggests an evolutionary link to tumour necrosis factor. Curr Biol 8 (1998) 335-338
11. Wong G.W., Wang J., Hug C., Tsao T.S., and Lodish H.F. A family of Arcp30/adiponectin structural and functional paralogs. Proc Natl Acad Sci 101 (2004) 10302-10307
12. Yokota T., Oritani K., Takahashi I., et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96 (2000) 1723-1732
13. Pajvani U.B., Du X., Combs T.P., et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity. J Biol Chem 278 (2003) 9073-9085
14. Fruebis J., Tsao T.S., Javorschi S., et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci 98 (2001) 2005-2010
15. Yamauchi T., Kamon J., Ito Y., et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423 (2003) 762-769
16. Hug C., Wang J., Ahmed N.S., et al. T-cadherin is a receptor for hexameric and high molecular weight forms of Arcp 30/adiponectin. Proc Natl Acad Sci 101 (2004) 10308-10313
17. Kadowaki T., and Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 26 (2005) 439-451
18. Maeda N., Shimomura I., Kishida K., et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8 (2002) 731-737
19. Yamauchi T., Kamon J., Waki H., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7 (2001) 941-946
20. Xu A., Wang Y., Keshaw H., et al. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 112 (2003) 91-100
21. Yamauchi T., Kamon J., Minokoshi Y., et al. Adiponectin stimulates glucose utilisation and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8 (2002) 1288-1295
22. Adamczak M., Rzepka E., Chudek J., and Wiecek A. Ageing and plasma adiponectin concentrations in apparently healthy males and females. Clin Endocrinol 62 (2005) 114-118
23. Lanfranco F., Zitzman M., Simoni M., and Nieschlag E. Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy. Clin Endocrinol (2004) 500-507
24. Hotta K., Funahashi T., Arita Y., et al. Plasma concentrations of a novel, adipose specific protein adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20 (2000) 1595-1599
25. Yang W.S., Lee W.J., Funahashi T., et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86 (2001) 3815-3819
26. Maeda N., Takahashi M., Funahashi T., et al. PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50 (2005) 2094-2099
27. Nilsson L., Binart N., Bohlooly Y., et al. Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue. Biochem Biophys Res Commun 331 (2005) 1120-1126
28. 3-adrenergic agonists, retinoic acid, leptin and fasting. Biochem Biophys Acta 1584 (2002) 115-122
29. Fasshauer M., Klein J., Neumann S., Eszlinger M., and Paschke R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 290 (2002) 1084-1089
30. Choi K.M., Lee K.W., Seo J.A., et al. The association between plasma adiponectin, gherlin levels and cardiovascular risk factors. Eur J Endocrinol 150 (2004) 715-718
31. Zietz B., Herfarth H., Paul G., et al. Adiponectin represents an independent cardiovascular risk factor predicting serum HDL-cholesterol levels in type 2 diabetes. FEBS Lett 545 (2003) 103-104
32. Nakamura Y., Shimada K., Fukada D., et al. Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart 90 (2004) 528-533
33. Higashiura K., Ura N., Ohata J., et al. Correlations of adiponectin level with insulin resistance and atherosclerosis in Japanese male populations. Clin Endocrinol 61 (2004) 753-759
34. Chan K.C., Chou H.H., Wu D.J., Wu Y.L., and Huang C.N. Diabetes mellitus has an additional effect on coronary artery disease. To decrease adiponectin levels. Jpn Heart J 45 (2004) 921-927
35. Shetty G.K., Economides P.A., Horton E.S., Mantzoros C.S., and Veves A. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 27 (2004) 2450-2457
36. Singhal A., Jamieson N., Fewtrell M., et al. Adiponectin predicts insulin resistance but not endothelial function in young healthy adolescents. J Clin Endocrinol Metab (2005) [Epub 10/05/05]
37. Kojima S., Funahashi T., Maruyoshi H., et al. Levels of the adipocyte-derived plasma protein, adiponectin, have a close relationship with atheroma. Thromb Res 115 (2005) 483-490
38. Butte N.F., Comuzzie A.G., Cai G., et al. Genetic and environmental factors influencing fasting serum adiponectin in hispanic children. J Clin Endocrinol Metab 90 (2005) 4170-4176
39. Pellemé F., Smith U., Funahashi T., et al. Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients. Diabetes 52 (2003) 1182-1186
40. Schulze M.B., Rimm E., Shai I., Rifai N., and Hu F.B. Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. Diabetes Care 27 (2004) 1680-1687
41. Winzer C., Wagner O., Festa A., et al. Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care 27 (2004) 1721-1727
42. Fernandez-Real J.M., Lopez-Bermejo A., Casamitjana R., and Ricart W. Novel interactions of adiponectin with the endocrine system and inflammatory parameters. J Clin Endocrinol Metab 88 (2003) 2714-2718
43. Mantzoros C.S., Li T., Manson J.E., Meigs J., and Hu F.B. Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes. J Clin Endocrinol Metab 90 (2005) 4542-4548
44. Martin L.J., Woo J.G., Daniels S.R., Goodman E., and Dolan L.M. The relationships of adiponectin with insulin and lipids are strengthened with increasing adiposity. J Clin Endocrinol Metab 90 (2005) 4255-4259
45. Valsamakis G., Chetty R., McTernan P.G., et al. Fasting serum adiponectin concentration is reduced in Indo-Asian subjects and is related to HDL cholesterol. Diabet Obes Metabol 5 (2003) 131-135
46. Bugianesi E., Pagotto U., Manini R., et al. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J Clin Endocrinol Metab 90 (2005) 3498-3504
47. Targher G., Bertolini L., Scala L., Poli F., Zenari L., and Falezza G. Decreased plasma adiponectin concentrations are closely associated with nonalcoholic hepatic steatosis in obese individuals. Clin Endocrinol 61 (2004) 700-703
48. Tshritter O., Fritsche A., Thamer C., et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 52 (2003) 239-243
49. Gonzalez-Sanchez J.L., Zabena C.A., Martinez-Larrad M.T., et al. An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance. Obes Res 13 (2005) 807-812
50. Salmenniemi U., Zacharova J., Ruotsalainen E., et al. Association of adiponectin level and variants in the adiponectin gene with glucose metabolism, energy expenditure and cytokines in offspring of type 2 diabetic patients. J Clin Endocrinol Metab 90 (2005) 4216-4223
51. Weyer C., Funahashi T., Tanaka S., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86 (2001) 1930-1935
52. Lihn A.S., Østergärd T., Nyholm B., et al. Adiponectin expression in adipose tissue is reduced in first-degree relatives of type 2 diabetic patients. AJP: Endocrinol Metab 284 (2003) 443-448
53. Stefan N., Vozarova B., Funahashi T., et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 50 (2002) 1884-1888
54. Thamer C., Machann J., Tschritter O., et al. Relationship between serum adiponectin concentration and intramyocellular lipid stores in humans. Horm Metab Res 34 (2003) 646-649
55. Tomas E., Tsao T.S., Saha A.K., et al. Enhanced muscle fat oxidation and glucose transport by ARCP30 globular domain: acetyl-coA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci 99 (2002) 16309-16313
56. Fu Y., Luo N., Klein R.L., and Garvey W.T. Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation: potential role in autoregulation of adipocyte metabolism and adipose mass. J Lipid Res 46 (2005) 1369-1379
57. Hotamisligil G.S., Shargill N.S., and Spieglman B.M. Adipocyte expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
58. Kahn B.B., Alquier T., Carling D., and Hardie D.G. AMP-activated protein kinas: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1 (2005) 15-25
59. Ruderman N.B., Saha A.K., and Kraegen E.W. Minireview: malonylCoA, AMP-activated protein kinase, and adiposity. Endocrinology 144 (2003) 5166-5171
60. Zurlo F., Lillioja S., Esposito-Del P.A., et al. Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ. AJP: Endocrinol Metab 259 (1990) E650-E657
61. Larson D.E., Ferraro R.T., Robertson D.S., and Ravussin E. Energy metabolism in weight-stable postobese individuals. Am J Clin Nutr 62 (1995) 739
62. Weiss R., Taksali S.E., Dufour S.D., et al. The "obese insulin-sensitive" adolescent: importance of adiponectin and lipid partitioning. J Clin Endocrinol Metab 90 (2005) 3731-3737
63. Nedvidkova J., Smitka K., and Hainer V. Adiponectin, an adipocyte-derived protein. Physiol Res 54 (2005) 133-140
64. Tataranni P.A., and Ortega E. A burning question. Does an adipokine-induced activation of the immune system mediate the effect of overnutrition in type 2 diabetes. Diabetes 54 (2005) 927
65. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. NEJM 352 (2005) 1685-1695
66. Okomoto Y., Kihara S., Ouchi N., et al. Adiponectin reduces atherosclersosis in apolipoprotein E-deficient mice. Circulation 106 (2002) 2767-2770
67. Ouchi N., Ohishi M., Kihara S., et al. Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 42 (2003) 231-234
68. Shibata R., Ouchi N., Ito M., et al. Adiponectin-mediated modulation of hypertrophic signals in the HEART. Nat Med 12 (2004) 1384-1389
69. Shimbukuro M., Higa N., Asahi T., et al. Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab 88 (2003) 3236-3240
70. Fernandez-Real J.M., Castro M., Vazquez G., et al. Adiponectin is associated with vascular function independent of insulin sensitivity. Diabetes 27 (2004) 739-745
71. Tan K.C.B., Xu A., Chow W.S., et al. Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J Clin Endocrinol Metab 89 (2004) 765-769
72. Diez J.J., Igelias P., Fernandez-Reyes M.J., et al. Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end stage renal disease. Clin Endocrinol 62 (2005) 242-249
73. Ignacy I., Chudek J., Adamczak M., et al. Reciprocal association of plasma adiponectin and serum C-reactive protein concentration in haemodialysis patients with end stage kidney disease: a follow up study. Nephron Clin Pract 101 (2005) 18-24
74. Bruun J.M., Lihn A.S., Verdich C., et al. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. AJP: Endocrinol Metab 285 (2003) E527-E533
75. Iwashima Y., Katsuya T., Ishikawa K., et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 43 (2004) 1318-1323
76. Ouchi N., Kihara S., Funahashi T., et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 107 (2003) 671-674
77. Pilz S., Horejsi R., Möller R., et al. Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin. J Clin Endocrinol Metab 90 (2005) 4792-4796
78. Yilmaz M.I., Sonmez A., Kilic S., et al. The association of plasma adiponectin levels with hypertensive retinopathy. Eur J Endocrinol 152 (2005) 233-240
79. Komatsu M., Ohfusa H., Sato Y., et al. Strong inverse correlation between serum adiponectin and heart rate-corrected QT interval in an apparently healthy population. Diabetes Care 27 (2004) 1237-1238
80. Iwashima Y., Katsuya T., Ishikawa K., et al. Association of hypoadiponectinemia with smoking habit in men. Hypertension 45 (2005) 1094-1100
81. Thamer C., Stefan N., Stumvoll M., Haring H., and Fritsche A. Reduced adiponectin serum levels in smokers. Atherosclerosis 179 (2004) 421-422
82. Iacobellis G., Pistilli D., Gucciardo M., et al. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine 29 (2005) 251-255
83. Kojima S., Funahashi T., Sakamoto T., et al. The variation of plasma concentrations of a novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarction. Heart 89 (2003) 667-668
84. Nakanishi S., Yamane K., Kamei N., et al. A protective effect of adiponectin against oxidative stress in Japanese Americans: the association between adiponectin or leptin and urinary isoprostane. Metab Clin Exp 54 (2005) 194-199
85. Chen M.P., Tsai J.C.R., Chung F.M., et al. Hypoadiponectinemia is associated with ischemic cerebrovascular disease. Arterioscler Thromb Vasc Biol 25 (2005) 821-826
86. Kawano T., Saito T., Yasu T., et al. Close association of hypoadiponectinemia with arteriosclerosis obliterans and ischemic heart disease. Metab Clin Exp 54 (2005) 653-656
87. Kumada M., Kihara S., Sumitsuji S., et al., and for the Osaka CAD Study Group. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23 (2003) 85-89
88. Pischon T., Girman C.J., Hotamisligil G.S., et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291 (2004) 1730-1737
89. Costacou T., Zgibor J.C., Evans R.W., et al. The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 48 (2005) 41-48
90. Ajuwon K.M., and Spurlock M.E. Adiponectin inhibits LPS-induced NF-κB activation and IL-6 production and increases PPARγ2 expression in adipocytes. Am J Physiol Regul Comp Physiol 288 (2005) R1220-R1225
91. Okomoto Y., Arita Y., Nishida M., et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res 32 (2000) 47-50
92. Chen H., Montagnani M., Funahashi T., Shimomura I., and Quon M. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 278 (2003) 45021-45026
93. Kobayashi H., Ouchi N., Kihara S., et al. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 94 (2004) e27-e31
94. Brakenhielm E., Veitonmaki N., Cao R., et al. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci (2005) 2476-2481
95. Kawanami D., Maemura K., Takeda N., et al. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem Biophys Res Commun 314 (2004) 415-419
96. Ouchi N., Kihara S., Arita Y., et al. Novel modulator for endothelial adhesion molecules. Adipocyte-derived plasma protein adiponectin. Circulation 100 (1999) 2473-2476
97. Malysko J., Malysko J.S., Brzosko S., Wolczynski S., and Mysliweic M. Adiponectin is related to CD146, a novel marker of endothelial cell activation/injury in chronic renal failure and peritoneally dialyzed patients. J Clin Endocrinol Metab 89 (2004) 4620-4627
98. Ouchi N., Kihara S., Arita Y., et al. Adipocyte-derived plasma protein, adiponectin. Suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103 (2001) 1057-1063
99. Arita Y., Kihara S., Ouchi N., et al. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 105 (2002) 2893-2898
100. Tsao T.S., Murrey H.E., Hug C., Lee D.H., and Lodish H.F. Oligomerization state-dependent activation of the NF-kB signalling pathway by adipocyte complement-related protein of 30 kDa (Arcp30). J Biol Chem 277 (2002) 29359-29362
101. Chandran M., Ciaraldi T., Phillips S.A., and Henry R.R. Adiponectin: more than just another fat cell hormone?. Diabetes Care 26 (2003) 2442-2448
102. Maeda K., Okubo K., Shimomura I., et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM 1 (adipose most abundant gene transcript-1). Biochem Biophys Res Commun 221 (1996) 286-289
103. Takahashi M., Arita Y., Yamagata K., et al. Genomic structure and mutations in adipose specific gene, adiponectin. Int J Obes 24 (2000) 861-868
104. Francke S., Manraj M., Lacquemant C., et al. A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum Mol Genet 10 (2001) 2751-2765
105. Vionnet N., Hani E.-H., Dupont S., et al. Genomewide search for type 2 diabetes susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2 diabetes locus on chromosome 1q21q24. Am J Hum Genet (2000) 1470-1480
106. Vassuer F., Helbecque N., Dina C., et al. Single-nucleotide polymorphism haplotypes in the both proximal promotor and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 11 (2002) 2607-2614
107. Pollin T.I., Tanner K., O'Connell J.R., et al. Linkage of plasma adiponectin levels to 3q27 explained by association with variation in the APM1 gene. Diabetes 54 (2005) 268-274
108. Hara K., Boutin P., Mori Y., et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 51 (2002) 536-540
109. Berthier M.T., Houde A., Cote M., et al. Impact of adiponectin gene polymorphisms on plasma lipoprotein and adiponectin concentrations of viscerally obese men. J. Lipid Res. 46 (2005) 237-244
110. Yang W.S., Tsou P.L., Lee W.J., et al. Allele-specific differential expression of a common adiponectin gene polymorphism related to obesity. J Mol Med 81 (2003) 428-434
111. Xita N., Georgiou I., Chatzikyriakidou A., et al. Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome. Clin Chem 51 (2005) 416-423
112. Stumvoll M., Tschritter O., Fritsche A., et al. Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity. Interaction with family history of type 2 diabetes. Diabetes 51 (2002) 37-41
113. Ukkola O., Ravussin E., Jacobson P., Sjostrom L., and Bouchard C. Mutations in the adiponectin gene in lean and obese subjects from the Swedish obese subjects cohort. Metabolism 52 (2003) 881-884
114. Menzaghi C., Ercolino T., Paola R.D., et al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 51 (2002) 2306-2312
115. Femeron F., Aubert R., Siddiq A., et al., and for the epidemiologic data on the Insulin Resistance Syndrome (DESIR) Study Group. Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period. The epidemiologic data on the insulin resistance prospective study. Diabetes 53 (2004) 1150-1157
116. Zacharova J., Chiasson J.L., Laakso M., and and the STOP-NIDDM Study Group. The common polymorphisms (single nucleotide polymorphism [SNP] +45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial. Diabetes 54 (2005) 893-899
117. Qi L., Li T., Rimm E., et al. The +276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men. Diabetes 54 (2005) 1607-1610
118. Fillippi E., Sentinelli F., Trischitta V., et al. Association of the human adiponectin gene and insulin resistance. Eur J Hum Genet 12 (2004) 199-205
119. Qiao L., Maclean P.S., Schaak J., et al. C/EBPα regulates human adiponectin gene transcription through an intronic enhancer. Diabetes 54 (2005) 1744-1754
120. Vassuer F., Helbecque N., Lobbens S., et al. Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectin encoding (ACDC) gene promoter variants in morbid obesity: evidence for a role of ACDC in diabetisity. Diabetologia 48 (2005) 892-899
121. Gu H.F., Abulaiti A., Ostenson C.G., et al. Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish Caucasians. Diabetes 53 (2004) S31-S35
122. Populaire C., Mori Y., Dina C., et al. Does the -11377 promotor variant of APM1 gene contribute to the genetic risk for type 2 diabetes mellitus in Japanese families?. Diabetologia 46 (2003) 444-445
123. Vozarova de C., Hanson R.L., Funahashi T., et al. Common polymorphisms in the adiponectin gene ACDC are not associated with diabetes in Pima Indians. Diabetes 54 (2005) 284-289
124. Gibson F., and Froguel P. Genetics of the APM1 locus and its contribution to type 2 diabetes susceptibility in French Caucasians. Diabetes 53 (2004) 2977-2983
125. Ohashi K., Ouchi N., Kihara S., et al. Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease. J Am Coll Cardiol 43 (2004) 1195-1200
126. Waki H., Yamauchi T., Kamon J., et al. Impaired multimerization of human adiponectin mutants associated with diabetes. J Biol Chem 278 (2003) 40352-40363
127. Fillippi E., Sentinelli F., Romeo S., et al. The adiponectin gene SNP +276G > T associates with early-onset coronary artery disease and lower levels of adiponectin in younger coronary artery disease (age ≤ 50 years). J Mol Med (2005) [Epub 05/05/05]
128. Lacquemant C., Froguel P., Lobbens S., et al. The adiponectin gene SNP +45 is associated with coronary artery disease in type 2 (non-insulin dependent) diabetes mellitus. Diabet Med 21 (2004) 776-781
129. Bacci S., Menzaghi C., Ercolino T., et al. The +276G/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients. Diabet Care 27 (2004) 2015-2020
130. Qi L., Rimm E., Liu S., Rifai N., and Hu F.B. Dietary glycemic index, glycemic load, cereal fiber, and plasma adiponectin concentration in diabetic men. Diabet Care 28 (2005) 1022-1028
131. Jürimäe J., Purge P., and Jürimäe T. Adiponectin is altered after maximal exercise in highly trained male rowers. Eur J Appl Physiol 93 (2005) 502-505
132. Lee Y.Y., Lee N.S., Cho Y.M., et al. Genetic association study of adiponectin polymorphisms with risk of type 2 diabetes mellitus in Korean population. Diabet Med 22 (2005) 569-575
133. Kang E.S., Park S.Y., Kim H.J., et al. The influence of adiponectin gene polymorphism on the rosiglitazone response in patients with type 2 diabetes. Diabet Care 28 (2005) 1139-1144
134. Mousavinasab F., Tahtinen T., Jokelainen J., et al. Common polymorphisms in the PPAR[gamma]2 and IRS-1 genes and their interaction influence serum adiponectin concentration in young Finnish men. Mol Genet Metabol 84 (2005) 344-348
135. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The Lancet 364 (2004) 937-952